Using a previously cultured blood specimen with the culture or an isolate definitively identified to the level of genus and species, the analyst performs further testing to identify the pathogenic organism to the taxonomic level of type. The test amplifies (increases) the amount of DNA or RNA targets in the specimen, and uses probes for multiple targets (multiplex) to identify at least six targets that help specifically identify the organism and its resistance to medications.
For clinical responsibility, terminology, tips and additional info
start codify free trial.